A Study to Evaluate the Efficacy of Panitumumab in Patients with Incurable Cutaneous Squamous Cell Carcinoma (CSCC).
Phase of Trial: Phase II
Latest Information Update: 04 Dec 2015
At a glance
- Drugs Panitumumab (Primary)
- Indications Squamous cell cancer
- Focus Therapeutic Use
- 04 Dec 2015 New trial record